Hundreds of lawsuits are currently pending in a multidistrict litigation against pharmaceutical company Sanofi-Aventis, over its breast cancer chemotherapy drug, Taxotere. Plaintiffs allege the company failed to warn them of the risk of permanent hair loss caused by the drug.
It’s been a rough year for healthcare giant Johnson & Johnson (J&J). While the company is likely accustomed to fighting a high number of product liability lawsuits, 2016 saw many huge plaintiffs’ wins that will cost the company billions of dollars.
After stalling in the Senate for over a year, the 21st Century Cures Act was passed by Congress and signed into law by President Obama. The sweeping new legislation offers a number of reforms for the healthcare industry, but also comes with several concerns.
The FDA’s Office of Prescription Drug Promotion has been relatively quiet this year, but it appears the Agency is ending 2016 with a bang. The Office of Prescription Drug Promotion sent two letters to pharmaceutical companies Sanofi-Aventis and Celgene Corporation over television commercials it believes are misleading.
The litigation against Ethicon Inc. and Johnson & Johnson (J&J) over their defective pelvic mesh products has been ongoing for years now, but the first case finally came to an end. The Supreme Court of New Jersey declined to hear an appeal from Ethicon and J&J on the first pelvic mesh verdict awarded back in 2013.
The sixth Risperdal case to go to trial in the Philadelphia mass tort program against manufacturers Janssen Pharmaceuticals and Johnson & Johnson (J&J) has come to an abrupt end just 11 days into the trial. Earlier this week, Philadelphia Court of Common Pleas Judge Sean Kennedy dismissed the case.
The walls are quickly closing in on pharmaceutical giant Bayer A.G. The company has come under scrutiny for its controversial Essure contraceptive device and currently faces hundreds of lawsuits in state and federal courts across the country. Bayer has tried to dismiss Essure state court lawsuits on the grounds that state courts do not have jurisdiction over the device.
Pharmaceutical giant Bristol-Myers Squibb agreed to a multistate settlement over unfair and deceptive marketing practices concerning its popular antipsychotic medication Abilify. The company agreed to pay $19.5 million to be split among 43 states.
The clock is ticking for healthcare giant Johnson & Johnson (J&J) as the next baby powder cancer trial in Missouri quickly approaches. After three huge multimillion-dollar plaintiff wins in 2016, the company tried to postpone the upcoming 2017 trial.
The Essure contraceptive device manufactured by Bayer A.G. has come under fire in the U.S. for its serious and debilitating side effects. However, Bayer’s woes over Essure have moved international with two legal complaints filed in France.